论文部分内容阅读
目的:探讨在治疗2型糖尿病时选择沙格列汀联合胰岛素治疗的临床效果。方法:从2014年1月至2015年7月来我院治疗2型糖尿病的患者中选出98例,将其分为两个小组。为其中一组患者提供常规胰岛素治疗,作为对比组;另外一组患者则在对比组基础上联合应用沙格列汀,作为研究组。分别记录两组患者临床治疗效果。结果:研究组治疗总有效率为93.88%(46/49),明显低于对比组77.55%(38/49)。两组数据存在明显差异,具有统计学意义(P<0.05)。结论:采用沙格列汀联合胰岛素治疗2型糖尿病能够有效降低患者血糖值,提高治疗效果。
Objective: To investigate the clinical effect of saxagliptin and insulin in the treatment of type 2 diabetes mellitus. Methods: From January 2014 to July 2015, 98 patients who had type 2 diabetes mellitus in our hospital were selected and divided into two groups. One group of patients with conventional insulin therapy, as a control group; another group of patients in the control group on the basis of combination of saxagliptin, as the study group. The clinical effects of two groups were recorded. Results: The total effective rate of the study group was 93.88% (46/49), which was significantly lower than that of the control group (77.55%, 38/49). Significant differences between the two groups of data, with statistical significance (P <0.05). Conclusion: The combination of saxagliptin and insulin in the treatment of type 2 diabetes can effectively reduce the blood sugar and improve the therapeutic effect.